Wolf Richter: Coronavirus Drives Barrage of New Lobbying Activity
Follow the money – Congressional lobbying activity and who wins and who loses from coronavirus relief.
Read more...Follow the money – Congressional lobbying activity and who wins and who loses from coronavirus relief.
Read more...Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D
Read more...CalPERS staff is up to more dirty tricks. Push back by e-mail in public comments. Bad press already has them on the back foot.
Read more...Nassim Nicholas Taleb calls out one of CalPERS CIO Ben Meng’s Big Lies, and unearths an even bigger one.
Read more...A tidy case study into how much money it takes to buy Congressional votes.
Read more...Schumer’s “Heroes Fund” would create a new labor aristocracy
Read more...Using government spending power to bail out financiers and rentiers makes a travesty of MMT.
Read more...An article by Fed and FDIC researchers argues for hiding banks’ dirty laundry. Too bad the authorities didn’t make banks shape up instead.
Read more...Pipeline projects proceed, sometimes on a stealth basis, under cover of the COVID-19 crisis and despite the collapse of world oil prices.
Read more...The coronavirus crisis highlights the importance of ensuring wide access to repair information for lifesaving machines, such as ventilators.
Read more...Why you should hate the coronavirus “stimulus” bill.
Read more...As the world struggles with the pandemic, Boeing should be seen as the vector for a parallel epidemic. It’s Patient Zero in an epidemic of corporate failure. As we change the way we live our lives, corporations like Boeing should change the way they are run. Corporate mismanagement made this crisis worse and, if it doesn’t change, will make the recovery more difficult.
Read more...Granting “orphan” drug status to Gilead Sciences for remdesivir, its potential coronavirus treatment, is a massive boon to the company.
Read more...If the public is to be asked to give bailouts to businesses, it should get something back for its money. It needs to share in any upside.
Read more...The State Department’s global level 4 health advisory,recommending US citizens not travel internationally, has travel insurance implications.
Read more...